Targeting p73--a potential approach in cancer treatment

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• The p53 family comprises p53, p63, and p73, sharing roles in cell cycle arrest and apoptosis.
• Despite similarities, each family member exhibits unique functions and encodes variants with opposing roles in cancer.
• Functional interactions within the p53 family are critical for understanding cancer development.

Purpose of the Study:

• To review recent advancements in p73 research, focusing on its regulation, DNA damage response, and interactions with p53 and p63.
• To explore the impact of p73 on drug discovery and anticancer therapies.
• To highlight the clinical significance of the p53/p73 network in cancer prognosis and treatment.

Main Methods:

• Literature review of recent p73 research.
• Analysis of p73 regulation, DNA damage response pathways, and functional interactions.
• Discussion of p73's role in cancer development and therapeutic strategies.

Main Results:

• p73 exhibits complex regulation and a sophisticated response to DNA damage.
• Functional interactions among p53 family members are intricate and crucial.
• p73 variants have opposing roles, with full-length forms being pro-apoptotic and dominant-negative forms being oncogenic.

Conclusions:

• The p53/p73 network holds significant potential for cancer prognosis and targeted drug design.
• Understanding p73's tumor suppressor functions is vital for developing novel anticancer therapies.
• Recent research provides insights into p73's role in drug discovery and its implications for clinical practice.